Citigroup Inc Obs Eva Sa Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.14 - $0.21 $4,559 - $6,838	-32,566 Reduced 41.37%	46,158 $6,000
Q3 2022 Nov 10, 2022	BUY	$0.14 - $1.83 $10,790 - $141,045	77,074 Added 4671.15%	78,724 $11,000
Q2 2022 Aug 10, 2022	SELL	$1.34 - $2.08 $2,097 - $3,255	-1,565 Reduced 48.68%	1,650 $3,000
Q1 2022 May 12, 2022	BUY	$1.1 - $2.17 $922 - $1,820	839 Added 35.31%	3,215 $5,000
Q4 2021 Feb 10, 2022	BUY	$1.99 - $3.1 $4,728 - $7,365	2,376 New	2,376 $5,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.